SCHEMBL5145355

SCHEMBL5145355

NC(=O)Nc1ccc(-n2c3c(c4ccccc42)/C(=N/O)CCC3)c(Cl)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM4 Q14833 3/20 0.35
KDM4E B2RXH2 1/20 0.34
RECQL P46063 1/20 0.34
RAB9A P51151 8/20 0.34
ALDH1A1 P00352 6/20 0.34
MAPT P10636 6/20 0.34
NPC1 O15118 6/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
MAPK1 P28482 3/20 0.34
LMNA P02545 3/20 0.34
NFKB1 P19838 2/20 0.34
NFKB2 Q00653 2/20 0.34
RELA Q04206 2/20 0.34
TP53 P04637 1/20 0.34
CASP1 P29466 1/20 0.34
GAA P10253 1/20 0.34
THRB P10828 1/20 0.34
NPY2R P49146 5/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5145359 1.00 GRM4 (0.35) GRM4KDM4ERECQLRAB9AALDH1A1
SCHEMBL5147135 0.87 HDAC1 (0.43) GRM4KDM4ERECQLRAB9AALDH1A1
SCHEMBL5145476 0.80 BRD4 (0.42) GRM4MAOB
SCHEMBL5148480 0.77 PTGS1 (0.44) GRM4KDM4ERECQLRAB9AALDH1A1
SCHEMBL5147134 0.77 LMNA (0.45) GRM4KDM4ERECQLALDH1A1MAPT
SCHEMBL5145496 0.76 HDAC1 (0.35) KDM4EALDH1A1MAPTNPC1SMN1; SMN2
SCHEMBL14422441 0.76 MYC (0.35) KDM4ERECQLNPC1SMN1; SMN2MAPK1
SCHEMBL5145492 0.76 HDAC1 (0.35) KDM4EALDH1A1MAPTNPC1SMN1; SMN2
SCHEMBL14422443 0.75 TP53 (0.41) GRM4KDM4ERAB9AALDH1A1MAPT
SCHEMBL5147107 0.74 CYP2D6 (0.48) RAB9AALDH1A1MAPTNPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 GRM4 3565/4885KDM4E 2377/4885RECQL 121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.